001010 — Cedarhurst, New York

001010 is a clinical research site located in Cedarhurst, New York, United States 11516.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

001010 has participated in 1 clinical trials.

Therapeutic areas: Pain, Neoplasm, Cancer.

Sponsors: Grünenthal GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cedarhurst

Browse all research sites in New York · View every site in Cedarhurst

• Neurobehavioral Research
• Research Site
• Five Towns Neuroscience Research
• Clinical Site
• Neurocrine Clinical Site
• Investigational Site
• Cedarhurst
• Pfizer Investigational Site
• Teva Investigational Site 14772
• Otsuka Investigational Site
• Novartis Investigative Site
• Neumora Investigator Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 001010?

001010 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 001010 conducted?

001010 has 1 clinical trials on record. Their work covers Pain, Neoplasm, Cancer.

Is 001010 accredited by Crixeo Clinical Trials?

001010 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 001010?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.